Latest Review,CCL1 (CC Motif Chemokine Ligand 1

The CCL1 peptide, also known as I-309 or TCA-3, is a fascinating molecule that plays a significant role in the human immune system, particularly in the context of inflammation. This cytokine belongs to the CC chemokine family, a group of small proteins crucial for cell-to-cell communication within the immune system. Research into the CCL1 peptide has revealed its involvement in a variety of biological processes, making it a subject of considerable interest in immunology and related fields.

As an endogenous peptide in human, mouse, or rat, the CCL1 peptide is primarily secreted by activated T cells, monocytes, and endothelial cells. Its production is often triggered by inflammatory stimuli, highlighting its central role in the body's response to injury or infection. The primary function attributed to CCL1 is its ability to act as a chemoattractant. Specifically, scientific literature indicates that it is chemotactic for monocytes but not for neutrophils. This selective recruitment of immune cells is a finely tuned process, directing specific cellular players to sites of inflammation or tissue damage.

The mechanism by which CCL1 exerts its influence involves binding to its specific receptor, CCR8. This interaction is critical for initiating downstream signaling pathways. For instance, studies have shown that the CCL1/CCR8 axis is involved in the recruitment of Th2 cells, a subset of T lymphocytes important in allergic responses and defense against parasites. Furthermore, research suggests that CCL1 attracts monocytes, NK cells, immature B cells, and dendritic cells by interacting with the CCR8 receptor found on their cell surfaces. This broadens its impact on various immune cell populations.

Beyond its role in general inflammation, the CCL1 peptide has been implicated in more specific pathological processes. It is known to be involved in inflammatory processes through leukocyte recruitment and can play a key role in angiogenesis, the formation of new blood vessels, which is essential for tissue repair but also for tumor growth. Indeed, evidence suggests that CCL1 plays a role in inflammation by recruiting white blood cells and is crucial in processes such as angiogenesis, viral infection, and tumor development. In some contexts, CCL1 was overexpressed in TAM-like macrophages (Tumor-Associated Macrophages), further underscoring its connection to the tumor microenvironment and potentially influencing disease progression.

The biological activity of the CCL1 peptide is not static. Research has explored modifications to its structure and their functional consequences. For example, the C-Terminal Clipping of Chemokine CCL1/I-309 Enhances its activity. This indicates that the precise structure of the CCL1 peptide is important for its function. It has also been identified that CCL1 is an in vitro substrate for CPM, a metallo-carboxypeptidase that cleaves specific amino acids from the C-terminus of proteins and peptides. This enzymatic processing can modulate the peptide's activity.

The CCL1 peptide is encoded by the CCL1 Gene, also known as CC Motif Chemokine Ligand 1. This gene is a Protein Coding gene and is associated with certain diseases, including Kaposi Sarcoma and Mast-Cell Leukemia. The understanding of CCL1's genetic basis and its protein product is vital for developing diagnostic tools and therapeutic strategies.

The CCL1 peptide is a valuable tool for scientific research. Recombinant Human CCL1 and Human CCL1 / I-309 Protein are commercially available, allowing researchers to study its properties and functions in controlled laboratory settings. These preparations often come with detailed specifications, such as the purity of the protein, which is crucial for reliable experimental results. For instance, Human CCL1, Fc Tag has a purity of more than 95% and a molecular weight verified by SEC-MALS. Similarly, Recombinant Human CCL1 / I-309 Protein can be used to measure CCL1 levels or activity, providing high purity for studying immunology.

In summary, the CCL1 peptide is a multifaceted immune mediator. Its ability to recruit specific immune cells, particularly monocytes, to sites of inflammation, and its involvement in processes like angiogenesis and tumor development, highlight its significance. The binding of CCL1 to its receptor CCR8 initiates complex signaling cascades that influence immune responses. Further research into CCL1 and its interactions continues to shed light on its intricate roles in health and disease, and understanding its peptide nature is key to unlocking its full therapeutic and diagnostic potential. The study of CCL1 also encompasses various related molecules and receptors, such as CCL2, CCL11, CXCL immunology, and RANTES, all contributing to our comprehensive understanding of chemokine signaling.